ID   FBX11_MOUSE             Reviewed;         930 AA.
AC   Q7TPD1; A1A595; E9QP06; Q08EB9; Q08EC0; Q80UP0;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   16-OCT-2013, sequence version 3.
DT   07-APR-2021, entry version 149.
DE   RecName: Full=F-box only protein 11;
GN   Name=Fbxo11;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   STRAIN=C57BL/6J, and FVB/N; TISSUE=Fetal brain, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   CHARACTERIZATION OF JEFF MUTANT.
RX   PubMed=12943368; DOI=10.1007/s10162-002-3015-9;
RA   Hardisty R.E., Erven A., Logan K., Morse S., Guionaud S., Sancho-Oliver S.,
RA   Hunter A.J., Brown S.D., Steel K.P.;
RT   "The deaf mouse mutant Jeff (Jf) is a single gene model of otitis media.";
RL   J. Assoc. Res. Otolaryngol. 4:130-138(2003).
RN   [4]
RP   TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, CHARACTERIZATION OF JEFF AND MUTT
RP   MUTANTS, AND MUTAGENESIS OF SER-331 AND GLN-578.
RX   PubMed=17035249; DOI=10.1093/hmg/ddl403;
RA   Hardisty-Hughes R.E., Tateossian H., Morse S.A., Romero M.R., Middleton A.,
RA   Tymowska-Lalanne Z., Hunter A.J., Cheeseman M., Brown S.D.;
RT   "A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff
RT   mouse.";
RL   Hum. Mol. Genet. 15:3273-3279(2006).
CC   -!- FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F-box
CC       protein) E3 ubiquitin-protein ligase complex which mediates the
CC       ubiquitination and subsequent proteasomal degradation of target
CC       proteins, such as DTL/CDT2, BCL6 and PRDM1/BLIMP1. The SCF(FBXO11)
CC       complex mediates ubiquitination and degradation of BCL6, thereby
CC       playing a role in the germinal center B-cells terminal differentiation
CC       toward memory B-cells and plasma cells. The SCF(FBXO11) complex also
CC       mediates ubiquitination and degradation of DTL, an important step for
CC       the regulation of TGF-beta signaling, cell migration and the timing of
CC       the cell-cycle progression and exit. Binds to and neddylates
CC       phosphorylated p53/TP53, inhibiting its transcriptional activity.
CC       SCF(FBXO11) does not seem to direct ubiquitination of p53/TP53.
CC       {ECO:0000250|UniProtKB:Q86XK2}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of the SCF(FBXO11) complex consisting of CUL1, RBX1,
CC       SKP1 and FBXO11. Interacts with p53/TP53, BCL6 and DTL (when not
CC       phosphorylated). Interacts with PRMD1. {ECO:0000250|UniProtKB:Q86XK2}.
CC   -!- INTERACTION:
CC       Q7TPD1; P41183: Bcl6; NbExp=2; IntAct=EBI-15955324, EBI-6253762;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q7TPD1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7TPD1-2; Sequence=VSP_053353;
CC       Name=3;
CC         IsoId=Q7TPD1-3; Sequence=VSP_053353, VSP_053354;
CC   -!- TISSUE SPECIFICITY: At 9.5 dpc and 10.5 dpc, expression is restricted
CC       to developing heart tissue. By 11.5 dpc and 12.5 dpc, detected in liver
CC       and subsequently in muscle by 13.5 dpc. At 14.5 dpc, still detected in
CC       heart, liver and muscle and also in the developing secondary palate
CC       including the nasal, medial and oral epithelia of the palatal shelves.
CC       At 15.5 dpc and 16.5 dpc, expressed in lung, kidney, heart, liver,
CC       muscle and adrenal gland. At this time, fusion of the palate shelves
CC       has occurred, with expression confined to the nasal and oral epithelia.
CC       At 17.5 dpc, expression in the lung is confined to bronchial epithelial
CC       cells and is evident in bone marrow, skin, tissue macrophages,
CC       osteoblasts, kidney, liver and spleen. At 18.5 dpc, expressed in bone
CC       marrow, liver, kidney and muscle but decreases in heart and lung. At
CC       this time, first detected in the middle ear epithelium. At the newborn
CC       stage, expression is strong in the middle ear where it is confined to
CC       mucin-secreting cells, as well as persisting in bone marrow, kidney and
CC       liver. Middle ear expression persists in postnatal head tissue at 4 and
CC       13 days after birth and has declined by 21 days after birth. In the
CC       adult, expression is seen in alveolar macrophages of the lung,
CC       glomeruli and collecting tubules of the kidney, midbrain, heart and
CC       muscle. {ECO:0000269|PubMed:17035249}.
CC   -!- DEVELOPMENTAL STAGE: Not detected at 8.5 dpc. Expressed from 9.5 dpc
CC       throughout development and into adulthood (at protein level).
CC       {ECO:0000269|PubMed:17035249}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC087233; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC154673; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC049946; AAH49946.1; -; mRNA.
DR   EMBL; BC055343; AAH55343.1; -; mRNA.
DR   EMBL; BC117884; AAI17885.1; -; mRNA.
DR   EMBL; BC117885; AAI17886.1; -; mRNA.
DR   EMBL; BC128479; AAI28480.1; -; mRNA.
DR   CCDS; CCDS37717.1; -. [Q7TPD1-1]
DR   RefSeq; NP_001074503.1; NM_001081034.2. [Q7TPD1-1]
DR   RefSeq; NP_001335177.1; NM_001348248.1. [Q7TPD1-2]
DR   RefSeq; XP_006524267.1; XM_006524204.3.
DR   SMR; Q7TPD1; -.
DR   BioGRID; 230356; 6.
DR   DIP; DIP-59433N; -.
DR   IntAct; Q7TPD1; 1.
DR   STRING; 10090.ENSMUSP00000005504; -.
DR   iPTMnet; Q7TPD1; -.
DR   PhosphoSitePlus; Q7TPD1; -.
DR   PaxDb; Q7TPD1; -.
DR   PeptideAtlas; Q7TPD1; -.
DR   PRIDE; Q7TPD1; -.
DR   ProteomicsDB; 272960; -. [Q7TPD1-1]
DR   ProteomicsDB; 272961; -. [Q7TPD1-2]
DR   ProteomicsDB; 272962; -. [Q7TPD1-3]
DR   Antibodypedia; 15211; 343 antibodies.
DR   Ensembl; ENSMUST00000005504; ENSMUSP00000005504; ENSMUSG00000005371. [Q7TPD1-1]
DR   Ensembl; ENSMUST00000130379; ENSMUSP00000121206; ENSMUSG00000005371. [Q7TPD1-3]
DR   Ensembl; ENSMUST00000235112; ENSMUSP00000157024; ENSMUSG00000005371. [Q7TPD1-3]
DR   GeneID; 225055; -.
DR   KEGG; mmu:225055; -.
DR   UCSC; uc008dvf.1; mouse. [Q7TPD1-1]
DR   UCSC; uc008dvg.1; mouse. [Q7TPD1-3]
DR   CTD; 80204; -.
DR   MGI; MGI:2147134; Fbxo11.
DR   eggNOG; KOG1777; Eukaryota.
DR   GeneTree; ENSGT00530000063425; -.
DR   InParanoid; Q7TPD1; -.
DR   OrthoDB; 355502at2759; -.
DR   TreeFam; TF313602; -.
DR   Reactome; R-MMU-8951664; Neddylation.
DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 225055; 3 hits in 54 CRISPR screens.
DR   ChiTaRS; Fbxo11; mouse.
DR   PRO; PR:Q7TPD1; -.
DR   Proteomes; UP000000589; Chromosome 17.
DR   RNAct; Q7TPD1; protein.
DR   Bgee; ENSMUSG00000005371; Expressed in secondary oocyte and 300 other tissues.
DR   ExpressionAtlas; Q7TPD1; baseline and differential.
DR   Genevisible; Q7TPD1; MM.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005730; C:nucleolus; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IEA:InterPro.
DR   GO; GO:0016274; F:protein-arginine N-methyltransferase activity; ISO:MGI.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IMP:CACAO.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006464; P:cellular protein modification process; ISO:MGI.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   Gene3D; 2.160.20.10; -; 3.
DR   InterPro; IPR039448; Beta_helix.
DR   InterPro; IPR006633; Carb-bd_sugar_hydrolysis-dom.
DR   InterPro; IPR036047; F-box-like_dom_sf.
DR   InterPro; IPR001810; F-box_dom.
DR   InterPro; IPR029799; FBX11/DRE-1.
DR   InterPro; IPR007742; NosD_dom.
DR   InterPro; IPR022441; Para_beta_helix_rpt-2.
DR   InterPro; IPR006626; PbH1.
DR   InterPro; IPR012334; Pectin_lyas_fold.
DR   InterPro; IPR011050; Pectin_lyase_fold/virulence.
DR   InterPro; IPR003126; Znf_UBR.
DR   PANTHER; PTHR22990:SF20; PTHR22990:SF20; 1.
DR   Pfam; PF13229; Beta_helix; 2.
DR   Pfam; PF12937; F-box-like; 1.
DR   Pfam; PF05048; NosD; 1.
DR   Pfam; PF02207; zf-UBR; 1.
DR   SMART; SM00722; CASH; 3.
DR   SMART; SM00256; FBOX; 1.
DR   SMART; SM00710; PbH1; 19.
DR   SMART; SM00396; ZnF_UBR1; 1.
DR   SUPFAM; SSF51126; SSF51126; 3.
DR   SUPFAM; SSF81383; SSF81383; 1.
DR   TIGRFAMs; TIGR03804; para_beta_helix; 4.
DR   PROSITE; PS50181; FBOX; 1.
DR   PROSITE; PS51157; ZF_UBR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosome; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..930
FT                   /note="F-box only protein 11"
FT                   /id="PRO_0000119891"
FT   DOMAIN          156..202
FT                   /note="F-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00080"
FT   REPEAT          398..420
FT                   /note="PbH1 1"
FT   REPEAT          421..443
FT                   /note="PbH1 2"
FT   REPEAT          444..466
FT                   /note="PbH1 3"
FT   REPEAT          467..489
FT                   /note="PbH1 4"
FT   REPEAT          490..512
FT                   /note="PbH1 5"
FT   REPEAT          513..535
FT                   /note="PbH1 6"
FT   REPEAT          536..558
FT                   /note="PbH1 7"
FT   REPEAT          559..581
FT                   /note="PbH1 8"
FT   REPEAT          582..604
FT                   /note="PbH1 9"
FT   REPEAT          605..627
FT                   /note="PbH1 10"
FT   REPEAT          628..650
FT                   /note="PbH1 11"
FT   REPEAT          651..673
FT                   /note="PbH1 12"
FT   REPEAT          674..696
FT                   /note="PbH1 13"
FT   REPEAT          697..719
FT                   /note="PbH1 14"
FT   REPEAT          720..742
FT                   /note="PbH1 15"
FT   REPEAT          743..765
FT                   /note="PbH1 16"
FT   REPEAT          766..788
FT                   /note="PbH1 17"
FT   REPEAT          789..811
FT                   /note="PbH1 18"
FT   REPEAT          812..833
FT                   /note="PbH1 19"
FT   ZN_FING         836..907
FT                   /note="UBR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00508"
FT   VAR_SEQ         1..87
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_053353"
FT   VAR_SEQ         152
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_053354"
FT   MUTAGEN         331
FT                   /note="S->L: In Mutt mutant; 13% of heterozygotes show a
FT                   reduced startle response to a toneburst of 24 kHz and a
FT                   mild craniofacial abnormality. 17% of homozygotes show
FT                   perinatal lethality. Surviving homozygotes demonstrate a
FT                   marked craniofacial abnormality and reduced hearing."
FT                   /evidence="ECO:0000269|PubMed:17035249"
FT   MUTAGEN         578
FT                   /note="Q->L: In Jeff mutant; heterozygotes are deaf with
FT                   chronic proliferative otitis media, have a shortened snout
FT                   and occipital region, and are smaller than wild-type
FT                   littermates. Homozygotes demonstrate perinatal lethality
FT                   due to respiratory problems, are born with upper eyelids
FT                   open and show clefting of the hard or soft palate as well
FT                   as facial clefting."
FT                   /evidence="ECO:0000269|PubMed:12943368,
FT                   ECO:0000269|PubMed:17035249"
FT   CONFLICT        251
FT                   /note="G -> R (in Ref. 2; AAI17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        694
FT                   /note="V -> F (in Ref. 2; AAH49946)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   930 AA;  103728 MW;  0F644A34F1936393 CRC64;
     MNSVRAANRR PRRVSRPRPV QQQQQQPPQQ PPPQPPQQQP PPQPPQQPPQ QQPPPPPQQQ
     PPPPPPPPPP PPQDRNNAGE RDDVPADMVA EESGPGAQNS PYQLRRKTLL PKRTACPTKS
     SMEGASTSTT ENFGHRAKRA RVSGKSQDLS AAPAEQYLQE KLPDEVVLKI FSYLLEQDLC
     RAACVCKRFS ELANDPILWK RLYMEVFEYT RPMMHPEPGK FYQINPEEYE HPNPWKESFQ
     QLYKGAHVKP GFAEHFYSNP ARYKGRENML YYDTIEDALG GVQEAHFDGL IFVHSGIYTD
     EWIYIESPIT MIGAAPGKVA DKVIIENTRD STFVFMEGSE DAYVGYMTIR FNPDDKSAQH
     HNAHHCLEIT VNCSPIIDHC IIRSTCTVGS AVCVSGQGAC PTIKHCNISD CENVGLYITD
     HAQGIYEDNE ISNNALAGIW VKNHGNPIIR RNHIHHGRDV GVFTFDHGMG YFESCNIHRN
     RIAGFEVKAY ANPTVVRCEI HHGQTGGIYV HEKGRGQFIE NKIYANNFAG VWITSNSDPT
     IRGNSIFNGN QGGVYIFGDG RGLIEGNDIY GNALAGIQIR TNSCPIVRHN KIHDGQHGGI
     YVHEKGQGVI EENEVYSNTL AGVWVTTGST PVLRRNRIHS GKQVGVYFYD NGHGVLEDND
     IYNHMYSGVQ IRTGSNPKIR RNKIWGGQNG GILVYNSGLG CIEDNEIFDN AMAGVWIKTD
     SNPTLRRNKI HDGRDGGICI FNGGRGLLEE NDIFRNAQAG VLISTNSHPV LRKNRIFDGF
     AAGIEITNHA TATLEGNQIF NNRFGGLFLA SGVNVTMKDN KIMNNQDAIE KAVSRGQCLY
     KISSYTSYPM HDFYRCHTCN TTDRNAICVN CIKKCHQGHD VEFIRHDRFF CDCGAGTLSN
     PCTLAGEPTH DTDTLYDSAP PIESNTLQHN
//
